Purchase Order 75D30124P18496
Award Date 7/29/24
Potential Completion Date 7/20/29
Potential Value $176K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Illumina, Inc. is for the procurement of a MiSeq System, a genetic sequencing platform and associated consumables and services. The $93,529 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The contract does not have a set-aside designation. Illumina is a leading manufacturer of advanced genetic sequencing instruments, reagents, and bioinformatics software. The company has been awarded multiple federal...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $101,280.02, was awarded by the Centers for Disease Control and Prevention (CDC) for the provision of a reagent kit. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the National Institutes of Health (NIH), U.S....
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and software. The contract is for the purchase of a MiSeq System, a benchtop DNA sequencing platform, for $95,931. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received other federal prime and subcontract awards from agencies like the National Institutes of Health (NIH),...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $236,726.60 contract is for a service agreement to provide the CDC with Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software. The contract does not have a set-aside designation and has an ultimate completion date of August 31, 2026....
- This federal contract award is for a Delivery Order issued to Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $29,862.37 Firm Fixed Price contract was awarded on September 15, 2020 by a civilian federal agency, with an ultimate completion date of November 11, 2022. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of goods, has been awarded multiple federal contracts and Indefinite...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, with a potential value of $159,999.10. The contract has a completion date of September 14, 2023 and was awarded on September 15, 2022. Illumina has previously received federal contract awards from agencies such as the NIH, USDA, and VA to provide a range of sequencing systems, reagents, and...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
- This federal contract award, valued at $142,053.98, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a manufacturer of genomic sequencing equipment and reagents. The contract is for the provision of laboratory equipment, specifically various Illumina sequencing systems including NextSeq, NovaSeq, MiSeq, and iSeq, as well as associated consumables, sample preparation kits, and bioinformatics products. Illumina has previously been awarded other federal...